Document is current
Any future updates will be listed below
-
Authors
Peng, Enuo
Zeng, Yayue
He, Da
Tan, Xiaojun
Xu, Dabao https://orcid.org/0009-0006-5486-763X
Zhao, Xingping
-
Funding
Funding for this research was provided by:
the Hunan Provincial Clinical Medical Technology Innovation Guiding Project (2021SK52404, 2021SK53704)
the Scientific Research Program of FuRong Laboratory (2023SK2109)
the Key Research and Development Program of Hunan province (2022SK2033)
the Hunan Natural Science Foundation (2024JJ9154)
- License Information
-
More Information
Article History
Received: 27 September 2024
Accepted: 23 April 2025
First Online: 1 May 2025
Declarations
:
: The study was approved by the Reproductive Medicine Ethics Committee of Xiangtan Central Hospital in 22 March 2018 (s20180322), and registered in Chinese Clinical Trial Registry in 22 June 2018 (registration number: CHICTR1800016769). Title of the approved project: Study on autologous endometrium in cell therapy of Asherman syndrome. Participant were informed of the content of the study and signed informed consent.
: Not applicable.
: The authors declare no conflict of interest.
